Extensive study of the autooxidation products of apomorphine and its pharmacologically active derivatives
Authors:
- 14 September 2011
- journal article
- research article
- Published by Elsevier in Journal of Molecular Structure
- Vol. 1002 (1-3) , 37-44
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- N-Substituted-2-alkyl- and 2-arylnorapomorphines: Novel, highly active D2 agonistsBioorganic & Medicinal Chemistry, 2009
- Synthesis and neuropharmacological characterization of 2-O-substituted apomorphinesBioorganic & Medicinal Chemistry, 2008
- Synthesis and neuropharmacological evaluation of 2-aryl- and alkylapomorphinesBioorganic & Medicinal Chemistry, 2008
- Advances in Development of Dopaminergic AporphinoidsJournal of Medicinal Chemistry, 2006
- Role of peroxidases in Parkinson disease: a hypothesisFree Radical Biology and Medicine, 2005
- An oxidized form of apomorphine fails to induce stereotypySchizophrenia Research, 2003
- Differential neurobehavioral deficits induced by apomorphine and its oxidation product, 8-oxo-apomorphine-semiquinone, in ratsEuropean Journal of Pharmacology, 2002
- Toxic effects of apomorphine on rat cultured neurons and glial C6 cells, and protection with antioxidantsBiochemical Pharmacology, 2001
- Apoptosis, Neurotrophic Factors and NeurodegenerationReviews in the Neurosciences, 1997
- III. Researches into the chemical constitution of the opium bases. Part I.—On the action of hydrochloric acid on morphiaProceedings of the Royal Society of London, 1869